Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.41 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | IDH1 | O75874 | 9/20 | 0.37 |
| ▸ | IDH2 | P48735 | 2/20 | 0.37 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL129240 | 0.84 | P2RX7 (0.43) | P2RX7MBOAT4HTR2CSLC6A4HTR2B | |
| SCHEMBL25402832 | 0.81 | P2RX7 (0.45) | P2RX7MBOAT4HTR2CSLC6A4HTR2B | |
| SCHEMBL8190474 | 0.81 | KCNH2 (0.46) | P2RX7MBOAT4IDH1IDH2NOTUM | |
| SCHEMBL23343864 | 0.81 | P2RX7 (0.45) | P2RX7MBOAT4IDH1IDH2NOTUM | |
| SCHEMBL27983844 | 0.81 | P2RX7 (0.41) | P2RX7MBOAT4HTR2CSLC6A4HTR2B | |
| SCHEMBL1111276 | 0.81 | P2RX7 (0.41) | P2RX7MBOAT4HTR2CSLC6A4HTR2B | |
| SCHEMBL7037038 | 0.78 | KCNH2 (0.43) | P2RX7MBOAT4IDH2NOTUMADRB1 | |
| SCHEMBL28914699 | 0.78 | KCNH2 (0.66) | P2RX7MBOAT4NR3C1NOTUMKCNH2 | |
| SCHEMBL14834464 | 0.78 | P2RX7 (0.39) | P2RX7MBOAT4HTR2CSLC6A4HTR2B | |
| SCHEMBL18494297 | 0.78 | KCNH2 (0.56) | P2RX7MBOAT4IDH1IDH2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030212116-A1 | Heterocyclic imino compounds and fungicides and insecticides for agricultural and horitcultural use | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2003-11-13 | — | — | US | disclosed |
| EP-1243580-A1 | HETEROCYCLIC IMINO COMPOUNDS AND FUNGICIDES AND INSECTICIDES FOR AGRICULTURAL AND HORTICULTURAL USE | Nissan Chemical Industries, Ltd. (JP) | 2002-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030212116-A1 | Heterocyclic imino compounds and fungicides and insecticides for agricultural and horitcultural use | DDT, CBR3, CYP1B1 | P2RX7 1011/4885MBOAT4 4364/4885HTR2C 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.